Clinical Trials
13 trialsNCT05948943 2026-05-12
EPIK-L1
Novartis
Phase 2/3 Recruiting
NCT05983159 2026-05-05
TARGET-VM
Murdoch Childrens Research Institute
Phase 2 Recruiting
NCT07189832 2026-04-28
Bleomycin Intralesional Injections of Cystic Hygromas
Delta University for Science and Technology
Phase NA Completed
NCT06239480 2026-03-27
SELVA
Palvella Therapeutics, Inc.
Phase 3 Active not recruiting
NCT06943703 2025-04-24
Bleomycin as an Effective and Curative Adjunct Therapy for Lymphangioma
National Children's Hospital, Vietnam
Completed
NCT06892964 2025-03-25
IReg-LM
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase NA Recruiting
NCT06257719 2024-02-14
Clinical Characteristics of Lymphatic Malformations
West China Hospital
Completed
NCT04836884 2022-04-21
Vascular Anomaly Pathology and Genomics Biopsy Study
Mayo Clinic
Phase NA Completed
NCT00576888 2019-09-16
VAC
Medical College of Wisconsin
Completed
NCT00866827 2019-01-11
Airway Vascular Lesions
University of Arkansas
Completed
NCT01290484 2015-06-19
A Study to Evaluate Sildenafil for the Treatment of Lymphatic Malformations
Stanford University
Phase 1/2 Completed
NCT00010452 2015-03-25
Study of Picibanil (OK432) Sclerotherapy in Children With Macrocystic Lymphatic Malformations
FDA Office of Orphan Products Development
Phase 2/3 Completed
NCT00577213 2012-10-26
Diagnosis of Hemangiomas and Vascular Malformations
University of Arkansas
Completed